Get the Stockscreener App
9.95
5.40%
0.51
After Hours:
10.26
0.31
+3.12%
Nyxoah Sa stock is traded at $9.95, with a volume of 18,449.
It is up +5.40% in the last 24 hours and up +9.46% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$9.44
Open:
$9.64
24h Volume:
18,449
Relative Volume:
0.31
Market Cap:
$372.02M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-5.6831
EPS:
-1.7508
Net Cash Flow:
$-60.34M
1W Performance:
+5.18%
1M Performance:
+9.46%
6M Performance:
+1.95%
1Y Performance:
+72.74%
1-Day Range:
$9.55
$9.95
1-Week Range:
$9.26
$9.95
52-Week Range:
$4.00
$20.00
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
Nyxoah Sa Stock (NYXH) Latest News
Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks
Nyxoah Appoints John Landry as Chief Financial Officer - GlobeNewswire
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN
Trend Tracker for (NYXH) - Stock Traders Daily
Publication relating to transparency notifications: Nyxoah - The Korea Bizwire
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
Publication relating to transparency notifications - GlobeNewswire
Publication relating to transparency notifications, Business Wires News - AsiaOne
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024, Business Wires News - AsiaOne
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewswire
Behind the Bell: Nyxoah SA - Nasdaq
Nyxoah raises $27M for US commercialization of sleep apnea technology - BioWorld Online
How To Trade (NYXH) - Stock Traders Daily
Nyxoah Shareholdings Shift: Hambrecht and BlackRock Update - TipRanks
Nyxoah (NASDAQ:NYXH) Price Target Cut to $17.00 - Defense World
Nyxoah shares price target cut by H.C. Wainwright - Investing.com India
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $17.00 - MarketBeat
Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference, Business Wires News - AsiaOne
Nyxoah price target lowered to $17 from $18 at H.C. Wainwright - TipRanks
Nyxoah Raises $27M Through US Healthcare Investor to Support Genio Launch - Sleep Review
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
BlackRock Acquires 3.25% Stake in Nyxoah SA - TipRanks
Nyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market Preparations By GuruFocus - Investing.com Canada
Information on the total number of voting rights and shares - GlobeNewswire
Nyxoah Secures $27 Million to Boost U.S. Presence - Yahoo Finance
Ratio Revelations: Nyxoah SA (NYXH)’s Financial Metrics in the Spotlight - The Dwinnex
Nyxoah sells 3 million shares, raises USD 27 million - Medical Buyer
Nyxoah Secures $27 Million for U.S. Market Expansion - TipRanks
Nyxoah Raises $27 Million through its At-the-Market Offering - GlobeNewswire
Contrasting PetVivo (NASDAQ:PETV) and Nyxoah (NASDAQ:NYXH) - Defense World
Trading (NYXH) With Integrated Risk Controls - Stock Traders Daily
Stifel maintains Buy rating on Nyxoah shares By Investing.com - Investing.com Australia
Nyxoah shares hold price target, buy rating on positive study data - Investing.com
Stifel maintains Buy rating on Nyxoah shares - Investing.com
Nyxoah (NASDAQ:NYXH) Rating Reiterated by HC Wainwright - MarketBeat
Nyxoah's SWOT analysis: OSA device maker's stock poised for us launch - Investing.com
HC Wainwright Reiterates Buy Rating for Nyxoah (NASDAQ:NYXH) - Defense World
CVI Holdings LLC Buys New Position in Nyxoah S.A. (NASDAQ:NYXH) - MarketBeat
Nyxoah’s Genio Shows Promise for OSA Management - TipRanks
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update - GlobeNewswire
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update - GlobeNewswire Inc.
Information on the total number of voting rights and shares: Nyxoah - The Korea Bizwire
(NYXH) Investment Analysis - Stock Traders Daily
Nyxoah (NASDAQ:NYXH) Trading Down 2.1% - Defense World
Nyxoah (NASDAQ:NYXH) Stock Price Down 2.1% - MarketBeat
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):